Skip to main content

Court Grants Temporary Stay On JUUL's Vape Products Ban

Court Grants Temporary Stay On JUUL's Vape Products Ban

Court Grants Temporary Stay On JUUL's Vape Products Ban

Introduction

Food and Drug Administration's (FDA) order to ban the sale of JUUL's e-cigarettes has been temporarily blocked by a federal court as the manufacturer has asked for additional time to file an appeal of the recent regulatory decision.

Earlier, FDA rejected the authorization of JUUL vaping products and asked the manufacturer to discontinue the sale and recall the products from the U.S. market, citing the long-term effects of teen vaping addiction.

JUUL introduced vape pens in a variety of flavors in 2015 with a design similar to a USB drive. This allowed the teens to hide their products and vaping habits from parents and school officials. Eventually, the e-cigarettes became popular among the teens, which increased the addiction problems throughout the nation.

The manufacturer's deceptive marketing through social media, and other mediums to lure the teens, additionally fueled the addiction crisis. These misleading strategies even led non-smokers to use vape pens. FDA issued a ban on the products to control the skyrocketing teen nicotine addiction rate.

JUUL denied the FDA's order and appealed the decision in the court. JUUL Lab’s Chief Regulatory Officer defended their products by stating that the products are compliant with the statutory standards that make the products appropriate for the protection of public health.

JUUL is even considering filing for Chapter 11 bankruptcy to deal with the ban as a majority of the revenue from the sale of the products for the manufacturer comes from the U.S.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Links Roundup Chemical to Long-Term Brain Damage

Categories: Roundup

A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…

Zimmer Biomet Gets FDA Approval for Cementless Partial Knee

Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…

Court Names Special Masters for Bard Mesh Claim Settlements

Categories: Hernia Mesh

The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!